A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Poland- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Poland83 clinical trials in Nowa Sol, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
PolandPhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
PolandEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
PolandA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PolandStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
PolandStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PolandStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new biological therapies and biosimilars for improved patient outcomes.
Multiple studies are investigating novel therapeutic approaches for patients who haven't responded to conventional treatments.
Comprehensive research into atopic dermatitis and plaque psoriasis, including studies for both adult and pediatric populations.
These trials aim to advance treatment options for moderate to severe skin conditions.
Groundbreaking research in Sjögren's Syndrome and systemic lupus erythematosus, testing novel therapeutic approaches.
Focus on developing targeted therapies for complex autoimmune conditions.
Studies addressing epilepsy and Alzheimer's-related conditions, including innovative treatment approaches for seizure management.
Research aims to improve quality of life for patients with neurological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.